ArticlePloS one2025
Human papilloma virus vaccination uptake and associated factors among adolescent girls in Merab Abaya district, Gamo zone, Southern Ethiopia: Mixed methods.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman papillomavirus (HPV) vaccination is a well-established global strategy for the prevention of cervical cancer. However, the uptake of the vaccine varies across regions and countries due to several factors. Although girls are at risk for cervical cancer, there are limited studies measuring vaccination uptake among female adolescents in the study area.
objectiveTo assess human papilloma virus vaccination uptake and associated factors among adolescent girls, in Merab Abaya district, Gamo Zone, southern Ethiopia, 2024.
methodA community-based cross-sectional mixed-method study was conducted among 626 adolescent girls selected using a two-stage sampling technique in Merab Abaya District, Gamo Zone, from February 1 to March 30, 2024. For the qualitative component, participants were selected using a purposive sampling technique. Data were entered using EpiData version 4.62 and analyzed using SPSS version 26. Logistic regression was performed to examine the association between the dependent variable and associated factors. Variables with a p-value < 0.05 in the multivariate analysis were considered statistically significant. For qualitative data analysis, OpenCode 4.02 software was used to conduct thematic content analysis.
resultA total of 601 adolescent girls participated in this study, yielding a response rate of 96%. Of these, 324 (53.9%; 95% CI: 49.9-57.9%) had received the human papillomavirus vaccine. Vaccine uptake was significantly associated with: Good knowledge about the HPV vaccine (AOR = 3.4; 95% CI: 2.14-5.38), A positive attitude toward the HPV vaccine (AOR = 1.7; 95% CI: 1.02-2.78), Recommendation from health workers to get vaccinated (AOR = 3.8; 95% CI: 2.25-6.50), Family support for vaccination (AOR = 7.1; 95% CI: 3.97-12.60). Qualitative findings identified mistrust of the HPV vaccine, irregular vaccine provision, and lack of information provision as major barriers to uptake.
conclusionIn this study, nearly fifty-four percent of adolescent girls had received the HPV vaccine. The overall uptake of the HPV vaccine among adolescent girls remains low. Good knowledge about the HPV vaccine, a positive attitude toward it, recommendations from health workers, and family support were significantly associated with vaccine uptake. Therefore, health facilities and schools should strengthen community-based health education aimed at promoting behavioral change regarding the HPV vaccine and focus on creating various training opportunities for health workers and teachers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.